Company News
Can-Fite Biopharma Rises 13% on Japan Patent
Can-Fite Biopharma Ltd shares jumped 13.3% after Japan Patent Office allowed patent No. 2025-049941 for obesity use of Namodenoson.
The allowed patent covers A3 adenosine receptor agonists, strengthen
